Microbot Medical Inc. Announces Issuance of a Canadian Patent Covering a Self-Cleaning Shunt
May 31, 2017 11:33 am UTC| Business
HINGHAM, Mass., May 31, 2017 -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, announced today that the...
Microbot Medical Inc. Announces Issuance of a Canadian Patent Covering a Self-Cleaning Shunt
May 31, 2017 11:33 am UTC| Business
HINGHAM, Mass., May 31, 2017 -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, announced today that the...
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
May 31, 2017 11:32 am UTC| Business
NORTHVALE, N.J., May 31, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today the issuance of European Patent No. 1615623 titled “Abuse-Resistant Oral Dosage Forms and Method of...
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
May 31, 2017 11:32 am UTC| Business
NORTHVALE, N.J., May 31, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today the issuance of European Patent No. 1615623 titled “Abuse-Resistant Oral Dosage Forms and Method of...
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
May 31, 2017 11:32 am UTC| Business
NORTHVALE, N.J., May 31, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today the issuance of European Patent No. 1615623 titled “Abuse-Resistant Oral Dosage Forms and Method of...
May 31, 2017 11:31 am UTC| Business
COLUMBIA, Md., May 31, 2017 -- EventTracker, a leader in security information and event management (SIEM), today announced that CEO A. N. Ananth will present on the importance of honeynet deception technology in...
Repligen to Present at Jefferies’ 2017 Global Annual Healthcare Conference
May 31, 2017 11:31 am UTC| Business
WALTHAM, Mass., May 31, 2017 -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that management will present at Jefferies’ 2017 Global Annual...